Goodluck Medical And Research Centre Profile
Key Indicators
- Authorised Capital ₹ 7.50 M
as on 15-11-2024
- Paid Up Capital ₹ 5.51 M
as on 15-11-2024
- Company Age 20 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 48.50 Cr
as on 15-11-2024
- Revenue %
(FY 2023)
- Profit -666.77%
(FY 2023)
- Ebitda -1010.31%
(FY 2023)
- Net Worth 2209.41%
(FY 2023)
- Total Assets 185.49%
(FY 2023)
About Goodluck Medical And Research Centre
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 5.51 M.
The company currently has active open charges totaling ₹48.50 Cr.
Aditi Mishra and Ramesh Mishra serve as directors at the Company.
- CIN/LLPIN
U85110UP2004PTC172097
- Company No.
124030
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Jan 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Gautam Buddha Nagar, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Goodluck Medical And Research Centre?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Aditi Mishra | Director | 25-Nov-2021 | Current |
Ramesh Mishra | Director | 09-Dec-2021 | Current |
Financial Performance of Goodluck Medical And Research Centre.
Goodluck Medical And Research Centre Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 666.77% decrease in profit. The company's net worth Soared by an impressive increase of 2209.41%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Goodluck Medical And Research Centre?
In 2023, Goodluck Medical And Research Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Canara Bank Creation Date: 04 Apr 2024 | ₹18.90 Cr | Open |
Canara Bank Creation Date: 23 Dec 2022 | ₹29.60 Cr | Open |
How Many Employees Work at Goodluck Medical And Research Centre?
Unlock and access historical data on people associated with Goodluck Medical And Research Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Goodluck Medical And Research Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Goodluck Medical And Research Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.